Table 4.

Summary of Adverse Events

	Placebo	Angiotensin II	Total
Patients with shock and renin above the median
Patients, n	73	55	128
TEAE	69 (94.5)	47 (85.5)	116 (90.6)
Grade 3/4 TEAE	61 (83.6)	39 (70.9)	100 (78.1)
Serious TEAE	61 (83.6)	39 (70.9)	100 (78.1)
Serious related TEAE	5 (6.8)	4 (7.3)	9 (7.0)
Patients with shock and renin below the median
Patients, n	63	64	127
TEAE	56 (88.9)	58 (90.6)	114 (89.8)
Grade 3/4 TEAE	40 (63.5)	40 (62.5)	80 (63.0)
Serious TEAE	36 (57.1)	38 (59.4)	74 (58.3)
Serious related TEAE	1 (1.6)	2 (3.1)	3 (2.4)

Definition of abbreviation: TEAE = treatment-emergent adverse event.

Data are n (%), unless otherwise indicated.